<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-2185</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МНЕНИЕ ПО ПРОБЛЕМЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>OPINION ON A PROBLEM</subject></subj-group></article-categories><title-group><article-title>Оценка потребности населения в дорогостоящих вмешательствах: существуют ли надежные критерии?</article-title><trans-title-group xml:lang="en"><trans-title>Assessment of the population demand for high-cost medical interventions: are there any reliable criteria?</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Самородская</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Samorodskaya</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>главный научный сотрудник научно-организационного отдела</p></bio><email xlink:type="simple">samor2000@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научный центр сердечно-сосудистой хирургии им. А.Н. Бакулева. Москва</institution></aff><aff xml:lang="en"><institution>A.N. Bakoulev Research Centre for Cardiovascular Surgery. Moscow</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>01</day><month>01</month><year>1970</year></pub-date><volume>9</volume><issue>8</issue><fpage>81</fpage><lpage>85</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Самородская И.В., 1970</copyright-statement><copyright-year>1970</copyright-year><copyright-holder xml:lang="ru">Самородская И.В.</copyright-holder><copyright-holder xml:lang="en">Samorodskaya I.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/2185">https://cardiovascular.elpub.ru/jour/article/view/2185</self-uri><abstract><p>В статье на основании вторичного анализа результатов международных исследований рассмотрены причины значительных географических различий в частоте выполнения кардиохирургических видов медицинской помощи. Оценивается влияние существующих различий на показатели смертности и методы определения потребности на основании данных о частоте применения лечения в странах мира и показателя “число больных, которых необходимо лечить”.</p></abstract><trans-abstract xml:lang="en"><p>The paper discussed the causes of the substantial geographical discrepancies in the rates of cardiosurgery interventions, based on the secondary analysis of international data. The impact of these differences on mortality levels is assessed. The methods for population demand assessment are reviewed, with the focus on the intervention rates across the countries and the “number needed to treat” parameter.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>потребность в операциях на сердце и сосудах</kwd><kwd>“число больных</kwd><kwd>которых необходимо лечить”</kwd><kwd>кардиохирургические методы лечения</kwd><kwd>географические различия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>demand for cardiovascular interventions</kwd><kwd>number needed to treat</kwd><kwd>cardiosurgery treatment methods</kwd><kwd>geographical differences</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Заключение о результатах проверки Счетной палаты по теме “Доступность и качество медицинской помощи населению Красноярского края как критерий эффективности использования финансовых ресурсов, направленных на здравоохранение”. http://www.ach-fci.ru/Krasnoyarsk/ activity/control/art2</mixed-citation><mixed-citation xml:lang="en">Заключение о результатах проверки Счетной палаты по теме “Доступность и качество медицинской помощи населению Красноярского края как критерий эффективности использования финансовых ресурсов, направленных на здравоохранение”. http://www.ach-fci.ru/Krasnoyarsk/ activity/control/art2</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Иванов А.В. Тихомиров А.В. Перспективы наноэкономики в развитии здравоохранения. Главный врач: хозяйство и право 2006; 6: 10-6.</mixed-citation><mixed-citation xml:lang="en">Иванов А.В. Тихомиров А.В. Перспективы наноэкономики в развитии здравоохранения. Главный врач: хозяйство и право 2006; 6: 10-6.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Стародубов В.И. Национальный проект “Здоровье” дает нам шанс вывести уровень оказания медицинской помощи на новые параметры. Менед здравоохр 2006; 10: 4-11.</mixed-citation><mixed-citation xml:lang="en">Стародубов В.И. Национальный проект “Здоровье” дает нам шанс вывести уровень оказания медицинской помощи на новые параметры. Менед здравоохр 2006; 10: 4-11.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Alter DA, Austin PC, Tu JV. Canadian Cardiovascular Outcomes Research Team. Community factors, hospital characteristics and inter-regional outcome variations following acute myocardial infarction in Canada. Can J Cardiol 2005; 21: 247-55.</mixed-citation><mixed-citation xml:lang="en">Alter DA, Austin PC, Tu JV. Canadian Cardiovascular Outcomes Research Team. Community factors, hospital characteristics and inter-regional outcome variations following acute myocardial infarction in Canada. Can J Cardiol 2005; 21: 247-55.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Batchelor WB, Peterson ED, Mark DB, A Comparison of U.S. and CanadianCardiac Catheterization Practices inDetecting Severe Coronary ArteryDisease After Myocardial Infarction: Efficiency, Yield and Long-Term Implications. JACC 1999; 34: 12-9.</mixed-citation><mixed-citation xml:lang="en">Batchelor WB, Peterson ED, Mark DB, A Comparison of U.S. and CanadianCardiac Catheterization Practices inDetecting Severe Coronary ArteryDisease After Myocardial Infarction: Efficiency, Yield and Long-Term Implications. JACC 1999; 34: 12-9.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Camm1 J, Klein H, Nisam S. The cost of implantable defibrillators: perceptions and reality. Eur Heart J 2007; 28(4): 392-7.</mixed-citation><mixed-citation xml:lang="en">Camm1 J, Klein H, Nisam S. The cost of implantable defibrillators: perceptions and reality. Eur Heart J 2007; 28(4): 392-7.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Cardiovascular Diseases in Europe: European Registries of Cardiovascular Diseases and Patient Management. Sophia Antipolis, France: Eur Society Cardiol 2004; р56.</mixed-citation><mixed-citation xml:lang="en">Cardiovascular Diseases in Europe: European Registries of Cardiovascular Diseases and Patient Management. Sophia Antipolis, France: Eur Society Cardiol 2004; р56.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Cosford PA, Leng GC. Screening for abdominal aortic aneurysm. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD002945. DOI: 10.1002/14651858.CD002945.pub2.</mixed-citation><mixed-citation xml:lang="en">Cosford PA, Leng GC. Screening for abdominal aortic aneurysm. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD002945. DOI: 10.1002/14651858.CD002945.pub2.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Denvir MA, Pell JP, Lee, AJ, et al. Variations in clinical decisionmaking between cardiologists and cardiac surgeons; a case for management by multidisciplinary teams? J Cardiothorac Surg 2006; 1: 2-5.</mixed-citation><mixed-citation xml:lang="en">Denvir MA, Pell JP, Lee, AJ, et al. Variations in clinical decisionmaking between cardiologists and cardiac surgeons; a case for management by multidisciplinary teams? J Cardiothorac Surg 2006; 1: 2-5.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Edmond JJ, French JK, Aylward PEG, et al. Variations in the Use of Emergency PCI for the Treatment of Re-infarction Following Intravenous Fibrinolytic Therapy: Impact on Outcomes in HERO-2. Eur Heart J 2007; 28(12): 1418-24.</mixed-citation><mixed-citation xml:lang="en">Edmond JJ, French JK, Aylward PEG, et al. Variations in the Use of Emergency PCI for the Treatment of Re-infarction Following Intravenous Fibrinolytic Therapy: Impact on Outcomes in HERO-2. Eur Heart J 2007; 28(12): 1418-24.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Epstein AM, Weissman JS, Schneider EC, et al. Race and Gender Disparities in Rates of Cardiac Revascularization: Do They Reflect Appropriate Use of Procedures or Problems in Quality of Care? Medical Care 2003; 41(11): 1240-55.</mixed-citation><mixed-citation xml:lang="en">Epstein AM, Weissman JS, Schneider EC, et al. Race and Gender Disparities in Rates of Cardiac Revascularization: Do They Reflect Appropriate Use of Procedures or Problems in Quality of Care? Medical Care 2003; 41(11): 1240-55.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Graham MM, Ghali WA, Faris PD, et al. APPROACH Investigators. Population rates of cardiaccatheterization and yield of high-risk coronary artery disease. CMAJ 2005; 173(1): 35-9.</mixed-citation><mixed-citation xml:lang="en">Graham MM, Ghali WA, Faris PD, et al. APPROACH Investigators. Population rates of cardiaccatheterization and yield of high-risk coronary artery disease. CMAJ 2005; 173(1): 35-9.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Health Statistics in the Nordic Countries 2006. NOMESCO, Copenhagen 2008, 284.</mixed-citation><mixed-citation xml:lang="en">Health Statistics in the Nordic Countries 2006. NOMESCO, Copenhagen 2008, 284.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24: 1231-43.</mixed-citation><mixed-citation xml:lang="en">Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24: 1231-43.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Leape LL, Weissman JS, Schneider EC, et al. Adherence to Practice Guidelines: The Role of Specialty Society Guidelines. Am Heart J 2003; 145(1): 19-26.</mixed-citation><mixed-citation xml:lang="en">Leape LL, Weissman JS, Schneider EC, et al. Adherence to Practice Guidelines: The Role of Specialty Society Guidelines. Am Heart J 2003; 145(1): 19-26.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Majumdar SR, McAlister FA, Furberg CtD. From Knowledge to Practice in Chronic Cardiovascular Disease: A Long and Winding Road. JACC 2004; 43(10): 1738-42.</mixed-citation><mixed-citation xml:lang="en">Majumdar SR, McAlister FA, Furberg CtD. From Knowledge to Practice in Chronic Cardiovascular Disease: A Long and Winding Road. JACC 2004; 43(10): 1738-42.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Martin RM, Hemingway H, Gunnell D, et al. Population need for coronary revascularisation: are national targets for England credible? Heart 2002; 88: 627-33.</mixed-citation><mixed-citation xml:lang="en">Martin RM, Hemingway H, Gunnell D, et al. Population need for coronary revascularisation: are national targets for England credible? Heart 2002; 88: 627-33.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">McGovern PG, Herlitz J, Pankow JS, et al. Comparison of medical care and one- and 12-month mortality of hospitalized patients with acute myocardial infarction in Minneapolis-St. Paul, Minnesota, United States of America and Goteborg, Sweden. Am J Cardiol 1997; 80: 557-62.</mixed-citation><mixed-citation xml:lang="en">McGovern PG, Herlitz J, Pankow JS, et al. Comparison of medical care and one- and 12-month mortality of hospitalized patients with acute myocardial infarction in Minneapolis-St. Paul, Minnesota, United States of America and Goteborg, Sweden. Am J Cardiol 1997; 80: 557-62.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Natarajan MK, Gafni A, Yusuf S. Determining optimal population rates of cardiac catheterization: A phantom alternative? CMAJ 2005; 173(1).</mixed-citation><mixed-citation xml:lang="en">Natarajan MK, Gafni A, Yusuf S. Determining optimal population rates of cardiac catheterization: A phantom alternative? CMAJ 2005; 173(1).</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Pell JP, Denvir MA. Angioplasty, bypass surgery or medical treatment: how should we decide? Heart 2002; 88: 451-2.</mixed-citation><mixed-citation xml:lang="en">Pell JP, Denvir MA. Angioplasty, bypass surgery or medical treatment: how should we decide? Heart 2002; 88: 451-2.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Ritchie JL, Wolk MJ, Hirshfeld JW, et al. Appropriate Clinical Care and Issues of “Self-Referral”. JACC 2004; 44(8): 1740-6.</mixed-citation><mixed-citation xml:lang="en">Ritchie JL, Wolk MJ, Hirshfeld JW, et al. Appropriate Clinical Care and Issues of “Self-Referral”. JACC 2004; 44(8): 1740-6.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Saia F, Lemos PA, Degertekin M, et al. Sirolimus-eluting stents for treatment of in-stent restenosis in the real world: Preliminary results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. JACC 2003; 41(Suppl II): 53A. Abstract 839FO-4.</mixed-citation><mixed-citation xml:lang="en">Saia F, Lemos PA, Degertekin M, et al. Sirolimus-eluting stents for treatment of in-stent restenosis in the real world: Preliminary results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. JACC 2003; 41(Suppl II): 53A. Abstract 839FO-4.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Wayne HH. Do You Really Need Bypass Surgery? A Second Opinion (Hardcover-2006). http://www.heartprotect.com/ mortality-stats.shtml</mixed-citation><mixed-citation xml:lang="en">Wayne HH. Do You Really Need Bypass Surgery? A Second Opinion (Hardcover-2006). http://www.heartprotect.com/ mortality-stats.shtml</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
